The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis

Cancer

Volumn 78, Issue 11, 1996, Pages 2307-2312

  Noffsinger, Amy E ^a   Miller, Mary A ^a   Cusi, Maria V ^a   Fenoglio Preiser, Cecilia M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

colon carcinoma; dysplasia; immunohistochemistry; inflammatory bowel disease; Ki 67; proliferation; ulcerative colitis

Indexed keywords

MONOCLONAL ANTIBODY KI 67; TUMOR MARKER;

ARTICLE; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CARCINOMA; COLON RESECTION; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; HUMANS; INTESTINAL MUCOSA; KI-67 ANTIGEN; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 0029824918     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2307::AID-CNCR6>3.0.CO;2-J     Document Type: Article

References (37)

1. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler RB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
2. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
3. Riddell RH. The precarcinomatous phase of ulcerative colitis. Curr Top Pathol 1976;63:179-219.
4. Hinton JM. Risk of malignant change in ulcerative colitis. Gut 1966;7:427-32.
5. MacDougall IPM. The cancer risk in ulcerative colitis. Lancet 1964;2:655-8.
6. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824-8.
7. Lennard-Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB. Cancer in colitis: assessment of the individual at risk by clinical and histological criteria. Gastroenterology 1977;73:1280-9.
8. Devroede GI, Dockerty MB, Sauer WG, Jackman RJ, Stickler GB. Cancer of the colon in patients with ulcerative colitis since childhood. Can J Surg 1972;15:369-74.
9. Hulten L, Kewenter J, Ahren C. Precancer and carcinoma in chronic ulcerative colitis: a histopathological and clinical investigation. Scand J Gastroenterol 1972;7:663-9.
10. Fuson JA, Farmer RG, Hawk WA, Sullivan BH. Endoscopic surveillance for cancer in chronic ulcerative colitis. Am J Gastroenterol 1980;73:120-6.
11. Cook MG, Goligher JC. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology 1975;68:1127-36.
12. Fenoglio CM, Pascal RR. Adenomatous epithelium, intraepithelial anaplasia, and invasive carcinoma in ulcerative colitis. Am J Dig Dis 1973;18:556-62.
13. Gewertz BL, Dent TL, Appelman HD. Implications of precancerous rectal biopsy in patients with inflammatory bowel disease. Arch Surg 1976;11:326-9.
14. Nugent FW, Haggitt RC, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis: preliminary report. Gastroenterology 1979;76:1-5.
15. Yardley JH, Keren DF. "Precancer" lesions in ulcerative colitis: a retrospective study of rectal biopsy and colectomy specimens. Cancer 1974;34:835-44.
16. Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion of mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366-74.
17. Dobbins WO. Current status of the precancer lesion in ulcerative colitis. Gastroenterology 1977;73:1431-3.
18. Myrvold HE, Kock NG, Ahren C. Rectal biopsy and precancer in ulcerative colitis. Gut 1974;15:301-4.
19. Weeks SC, Berouka D, Jarvis LR, Whitehead R. Video image analysis of AgNOR distribution in the normal and adenomatous colorectum. J Pathol 1992;166:139-45.
20. Bleiberg H, Mainguet P, Galand P. Cell renewal in familial polyposis: comparison between polyps and adjacent healthy mucosa. Gastroenterology 1972;63:240-5.
21. Risio M, Lipkin M, Candelaresi GL, Berone A, Coverlizza S, Rossini FP. Correlations between rectal mucosa cell proliferation and the clinical and pathological features of non-familial neoplasia of the large bowel. Cancer Res 1991; 51:1917-21.
22. Johnston PG, O'Brien MJ, Dervan PA, Carney DN. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol 1989;20:696-700.
23. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-66.
24. Morson BC, Sobin LH. Histologic typing of intestinal tumors. An international histologic classification of tumors. Geneva: World Health Organization, 1976;15:15-22.
25. Maskens AP, Deschner EE. Tritiated thymidine incorporation into epithelial cells of normal appearing colorectal mucosa in cancer patients. J Natl Cancer Inst 1977;58:1221-4.
26. Potten CS, Kellett M, Rew DA, Roberts SA. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli. Gut 1992;33:525-9.
27. Biasco G, Paganelli GM, Miglioli M, Brillanti S, Di Febo G, Gizzi G, et al. Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res 1990;50:1156-9.
28. Bleiberg H, Mainguet P, Galand P, Chretien J, Dupont-Mairesse N. Cell renewal in the human rectum: an in vitro autoradiographic study on active ulcerative colitis. Gastroenterology 1970;58:851-5.
29. Alpers DH, Philpott G, Grimme NL, Margolis DM. Control of thymidine incorporation in mucosal explants from patients with chronic ulcerative colitis. Gastroenterology 1980;78:470-8.
30. Jankowski J, McMenemin R, Yu C, Hopwood D, Wormsley KG. Proliferating cell nuclear antigen in oesophageal disease: correlation with transforming growth factor alpha expression. Gut 1992;33:587-91.
31. Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-9.
32. Gray MR, Hall PA, Nash J, Ansari J, Lane DP, Kingsnorth AN. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-76.
33. Hoang C, Polivka M, Valleur P, Hautefeuille P, Nemeth J, Galian A. Immunohistochemical detection of proliferating cells in colorectal carcinomas and adenomas with the monoclonal antibody Ki-67. Preliminary data. Virchows Archiv A Pathol Anat Histopathol 1989;414:423-8.
34. Shacter E, Beecham EJ, Covey JM, Kohn KW, Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 1988;9:2297-2304.
35. Ames BN. Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen 1989;14:66-77.
36. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Comm 1989;7:121-8.
37. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990;87:4533-7.